These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 21106641)

  • 1. Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties.
    Brandau S; Trellakis S; Bruderek K; Schmaltz D; Steller G; Elian M; Suttmann H; Schenck M; Welling J; Zabel P; Lang S
    J Leukoc Biol; 2011 Feb; 89(2):311-7. PubMed ID: 21106641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.
    Greifenberg V; Ribechini E; Rössner S; Lutz MB
    Eur J Immunol; 2009 Oct; 39(10):2865-76. PubMed ID: 19637228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocytic myeloid-derived suppressor cells are cryosensitive and their frequency does not correlate with serum concentrations of colony-stimulating factors in head and neck cancer.
    Trellakis S; Bruderek K; Hütte J; Elian M; Hoffmann TK; Lang S; Brandau S
    Innate Immun; 2013 Jun; 19(3):328-36. PubMed ID: 23160385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets.
    Lang S; Bruderek K; Kaspar C; Höing B; Kanaan O; Dominas N; Hussain T; Droege F; Eyth C; Hadaschik B; Brandau S
    Clin Cancer Res; 2018 Oct; 24(19):4834-4844. PubMed ID: 29914893
    [No Abstract]   [Full Text] [Related]  

  • 5. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
    Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
    J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid-derived suppressor cell heterogeneity and subset definition.
    Peranzoni E; Zilio S; Marigo I; Dolcetti L; Zanovello P; Mandruzzato S; Bronte V
    Curr Opin Immunol; 2010 Apr; 22(2):238-44. PubMed ID: 20171075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas signal promotes lung cancer growth by recruiting myeloid-derived suppressor cells via cancer cell-derived PGE2.
    Zhang Y; Liu Q; Zhang M; Yu Y; Liu X; Cao X
    J Immunol; 2009 Mar; 182(6):3801-8. PubMed ID: 19265159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer.
    Albeituni SH; Ding C; Liu M; Hu X; Luo F; Kloecker G; Bousamra M; Zhang HG; Yan J
    J Immunol; 2016 Mar; 196(5):2167-80. PubMed ID: 26810222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human splenic polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) are strategically located immune regulatory cells in cancer.
    Tavukcuoglu E; Horzum U; Yanik H; Uner A; Yoyen-Ermis D; Nural SK; Aydin B; Sokmensuer C; Karakoc D; Yilmaz KB; Hamaloglu E; Esendagli G
    Eur J Immunol; 2020 Dec; 50(12):2067-2074. PubMed ID: 32691408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α.
    Najjar YG; Rayman P; Jia X; Pavicic PG; Rini BI; Tannenbaum C; Ko J; Haywood S; Cohen P; Hamilton T; Diaz-Montero CM; Finke J
    Clin Cancer Res; 2017 May; 23(9):2346-2355. PubMed ID: 27799249
    [No Abstract]   [Full Text] [Related]  

  • 11. Myeloid differentiation treatment to diminish the presence of immune-suppressive CD34+ cells within human head and neck squamous cell carcinomas.
    Young MR; Wright MA; Pandit R
    J Immunol; 1997 Jul; 159(2):990-6. PubMed ID: 9218621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral blood neutrophil granulocytes from patients with head and neck squamous cell carcinoma functionally differ from their counterparts in healthy donors.
    Trellakis S; Farjah H; Bruderek K; Dumitru CA; Hoffmann TK; Lang S; Brandau S
    Int J Immunopathol Pharmacol; 2011; 24(3):683-93. PubMed ID: 21978700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maturation of dendritic cells in the presence of living, apoptotic and necrotic tumour cells derived from squamous cell carcinoma of head and neck.
    Kacani L; Wurm M; Schwentner I; Andrle J; Schennach H; Sprinzl GM
    Oral Oncol; 2005 Jan; 41(1):17-24. PubMed ID: 15598581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models.
    Greene S; Robbins Y; Mydlarz WK; Huynh AP; Schmitt NC; Friedman J; Horn LA; Palena C; Schlom J; Maeda DY; Zebala JA; Clavijo PE; Allen C
    Clin Cancer Res; 2020 Mar; 26(6):1420-1431. PubMed ID: 31848188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease.
    Trellakis S; Bruderek K; Dumitru CA; Gholaman H; Gu X; Bankfalvi A; Scherag A; Hütte J; Dominas N; Lehnerdt GF; Hoffmann TK; Lang S; Brandau S
    Int J Cancer; 2011 Nov; 129(9):2183-93. PubMed ID: 21190185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.
    Hoffmann TK; Dworacki G; Tsukihiro T; Meidenbauer N; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2002 Aug; 8(8):2553-62. PubMed ID: 12171883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma.
    Ochoa AC; Zea AH; Hernandez C; Rodriguez PC
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):721s-726s. PubMed ID: 17255300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
    Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells.
    Sinha P; Clements VK; Fulton AM; Ostrand-Rosenberg S
    Cancer Res; 2007 May; 67(9):4507-13. PubMed ID: 17483367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invariant NKT cells are resistant to circulating CD15+ myeloid-derived suppressor cells in patients with head and neck cancer.
    Horinaka A; Sakurai D; Ihara F; Makita Y; Kunii N; Motohashi S; Nakayama T; Okamoto Y
    Cancer Sci; 2016 Mar; 107(3):207-16. PubMed ID: 26679292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.